Lamotrigine Tablet, Extended Release
Product Images NDC 70518-4121

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 70518-4121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is information found on a package of LamoTRlIgine extended-release 50 mg tablets, with a quantity of 30 tablets. The medication is for prescription use only and has an NDC number of 70518-4121-00. It is manufactured by Dr. Reddy's in Shreveport, LA, with a source NDC of 55111-0718-30. The package should be kept out of reach of children and stored at 20-25°C(58-77°F), with excursions permitted to 15-30°C(59-86°F). It includes directions for use on the package insert and has been repackaged by Remedy Repack Inc. in Indiana, PA.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
This text provides information on Responder Rate (%) for Improvement and Worsening related to Lamotrigine ER Tablets. The table includes percentages for different categories such as 75%, 25%, 50%, 75%, and -100%. The data compares Placebo and Lamotrigine ER Tablets with the number of patients for each category.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
This text appears to be a chart showing response rates for a medication study comparing a placebo group with a group taking Lamotrigine Extended-release Tablets. The chart includes categories of improvement, worsening, and response rates for different percentages ranging from -100% to 100%. The study involved 120 participants in the placebo group and 116 participants in the Lamotrigine Extended-release Tablets group. The chart likely depicts the percentage of patients experiencing different outcomes in response to the medication.*
FDA Label Image

Pictures (Pictures)

Pictures (Pictures)
This is a description of various medications in different colors and shapes, with different dosages indicated. The medications are in tablet and capsule form with imprints in black ink for identification. The dosages range from 50mg to 300mg, and the medications are identified by codes such as R717, R718, R719, R720, R419, and R428. Some medications are round, while others are oval or modified capsule-shaped.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.